Pharmafile Logo
Pharmafocus logo
Advanced Search

First immunotherapy to treat advanced endometrial cancer on the NHS via Cancer Drugs Fund

February 8, 2022
Manufacturing and Production

GSK has shared that NICE is to issue a final appraisal determination (FAD) recommending the use of JEMPERLI®▼ (dostarlimab) via …

News
fejiomfxwaeana8

First gene therapy for rare genetic neurodegenerative disorder in children

February 7, 2022
Sales and Marketing

NICE has published a draft highly specialised technologies guidance, recommending gene therapy atidarsagene autotemcel for some children with the rare, …

News

NICE approves new treatment for chronic heart failure

February 7, 2022
Sales and Marketing

Empagliflozin (Jardiance®) has received a positive NICE recommendation for the treatment of chronic heart failure. NICE has announced that empagliflozin …

News

NICE recommends new combination for untreated advanced kidney cancer

February 4, 2022
Medical Communications

Bristol Myers Squibb (BMS) has announced that the National Institute for Health and Care Excellence (NICE) has issued a Final …

News

NICE issues FAD for Forxiga in adults with chronic kidney disease

February 4, 2022
Medical Communications

NICE has issued a Final Appraisal Document (FAD) recommending Forxiga (dapagliflozin) within its marketing authorisation for the treatment of adults …

News

Emmes supports new collaboration to advance COVID-19 research for children

February 4, 2022
Medical Communications

Clinical research organisation, Emmes, announced its role as a Data Coordinating Center on a team whose work has accelerated paediatric …

News

University of Oxford: new HIV variant discovered

February 4, 2022

A new and highly HIV variant with higher virulence, and more damaging health impacts, has been discovered in the Netherlands.In …

News

FDA orphan drug designation for treatment of rare blood cancer

February 3, 2022
Business Services

The FDA has granted orphan drug designation (ODD) to tamibarotene for the treatment of myelodysplastic syndrome (MDS). The Office of …

News

Vaginal HRT tablets to become available over the counter

February 3, 2022
Business Services

Vaginal oestrogen tablets, a type of hormone replacement therapy (HRT) – could become available in chemists soon, depending on the …

News

Illumina to advance precision medicine approach for late-stage cancer patients

February 3, 2022
Business Services

Illumina announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University in France, to assess the clinical value …

News

CMA fines firms £35m for illegal arrangement

February 3, 2022
Business Services

The Competition and Markets Authority (CMA) has fined firms over £35 million for an illegal arrangement in the supply of …

News

Novavax submits EUA to FDA for COVID-19 vaccine candidate

February 2, 2022
Research and Development

Maryland-based Novavax has announced it is submitting an EUA request to the FDA, for its COVID-19 vaccine candidate.Novavax initially planned …

News

Omicron subvariant BA.2 likely to have same severity as ‘original’, says WHO

February 2, 2022
Research and Development

The BA.2 form of the Omicron coronavirus variant is unlikely to be any more severe than the original BA.1 form, …

News

FDA approval of six-annual-dose HIV treatment

February 2, 2022
Research and Development

ViiV Healthcare has announced the FDA approval of Cabenuva (cabotegravir, rilpivirine) for every-two-month dosing for

News

First European filing submission for multiple myeloma bispecific antibody

February 2, 2022
Research and Development

Janssen has announced the submission of a Marketing Authorisation Application (MAA) to the EMA, seeking approval for off-the-shelf-bispecific antibody teclistamab, …

News

Technology on trial – the latest cogs in the clinical machine

February 1, 2022

From the integration of social media to everyday life, to the seeping of AI into our daily lives, the past …

Feature

Access denied: Is Brexit spelling bedlam for UK clinical trials?

February 1, 2022

Since Article 50 was triggered on the 29 March 2017, the UK’s pharmaceutical industry collectively held its breath, bracing itself …

Feature

Measles jab rate in England falls to ten percent below recommended rate

February 1, 2022
Medical Communications

Over one in 10 school entry-age children in England are at risk of measles due to not receiving their vaccine …

News

AI technology has the potential for breast cancer diagnosis

February 1, 2022
Manufacturing and Production

Academics at King’s College, London, and Guy’s and St Thomas’ NHS Foundation Trust, are using historical scans in a new …

News

WHO: COVID-19 hospital waste presents health threat

February 1, 2022
Manufacturing and Production

The vast amount of waste produced in tackling the COVID-19 pandemic poses a threat to human and environmental health, warns …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026